Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 22
1.
New Bioeth ; : 1-3, 2024 May 26.
Article En | MEDLINE | ID: mdl-38797719
2.
New Bioeth ; 29(4): 301-303, 2023 12.
Article En | MEDLINE | ID: mdl-37996251
3.
New Bioeth ; 29(2): 81-84, 2023 06.
Article En | MEDLINE | ID: mdl-37269093
5.
New Bioeth ; 24(3): 272-276, 2018 11.
Article En | MEDLINE | ID: mdl-30244667
6.
Kidney Int ; 94(3): 582-588, 2018 09.
Article En | MEDLINE | ID: mdl-29803405

Comparisons of survival between dialysis and nondialysis care for older adults with kidney failure have been limited to those managed by nephrologists, and are vulnerable to lead and immortal time biases. So we compared time to all-cause mortality among older adults with kidney failure treated vs. not treated with chronic dialysis. Our retrospective cohort study used linked administrative and laboratory data to identify adults aged 65 or more years of age in Alberta, Canada, with kidney failure (2002-2012), defined by two or more consecutive outpatient estimated glomerular filtration rates less than 10 mL/min/1.73m2, spanning 90 or more days. We used marginal structural Cox models to assess the association between receipt of dialysis and all-cause mortality by allowing control for both time-varying and baseline confounders. Overall, 838 patients met inclusion criteria (mean age 79.1; 48.6% male; mean estimated glomerular filtration rate 7.8 mL/min/1.73m2). Dialysis treatment (vs. no dialysis) was associated with a significantly lower risk of death for the first three years of follow-up (hazard ratio 0.59 [95% confidence interval 0.46-0.77]), but not thereafter (1.22 [0.69-2.17]). However, dialysis was associated with a significantly higher risk of hospitalization (1.40 [1.16-1.69]). Thus, among older adults with kidney failure, treatment with dialysis was associated with longer survival up to three years after reaching kidney failure, though with a higher risk of hospital admissions. These findings may assist shared decision-making about treatment of kidney failure.


Hospitalization/statistics & numerical data , Kidney Failure, Chronic/mortality , Renal Dialysis , Age Factors , Aged , Aged, 80 and over , Alberta/epidemiology , Female , Follow-Up Studies , Glomerular Filtration Rate , Hospitalization/trends , Humans , Kidney Failure, Chronic/therapy , Male , Retrospective Studies , Survival Analysis , Time Factors , Treatment Outcome
7.
New Bioeth ; 22(3): 255-256, 2016 Nov.
Article En | MEDLINE | ID: mdl-28219263
8.
New Bioeth ; 22(3): 253-255, 2016 Nov.
Article En | MEDLINE | ID: mdl-28219272
11.
New Bioeth ; 22(2): 87-88, 2016 Jul.
Article En | MEDLINE | ID: mdl-28219286
12.
New Bioeth ; 22(2): 157-159, 2016 Jul.
Article En | MEDLINE | ID: mdl-28219289
14.
Plant Cell ; 27(10): 2743-69, 2015 Oct.
Article En | MEDLINE | ID: mdl-26432862

The green alga Chlamydomonas reinhardtii is a useful model organism for investigating diverse biological processes, such as photosynthesis and chloroplast biogenesis, flagella and basal body structure/function, cell growth and division, and many others. We combined a highly synchronous photobioreactor culture system with frequent temporal sampling to characterize genome-wide diurnal gene expression in Chlamydomonas. Over 80% of the measured transcriptome was expressed with strong periodicity, forming 18 major clusters. Genes associated with complex structures and processes, including cell cycle control, flagella and basal bodies, ribosome biogenesis, and energy metabolism, all had distinct signatures of coexpression with strong predictive value for assigning and temporally ordering function. Importantly, the frequent sampling regime allowed us to discern meaningful fine-scale phase differences between and within subgroups of genes and enabled the identification of a transiently expressed cluster of light stress genes. Coexpression was further used both as a data-mining tool to classify and/or validate genes from other data sets related to the cell cycle and to flagella and basal bodies and to assign isoforms of duplicated enzymes to their cognate pathways of central carbon metabolism. Our diurnal coexpression data capture functional relationships established by dozens of prior studies and are a valuable new resource for investigating a variety of biological processes in Chlamydomonas and other eukaryotes.


Chlamydomonas reinhardtii/genetics , Transcriptome , Basal Bodies/metabolism , Cell Cycle , Cell Differentiation , Chlamydomonas reinhardtii/growth & development , Chlamydomonas reinhardtii/physiology , Chloroplasts/metabolism , Circadian Rhythm , Flagella/metabolism , Gene Expression Regulation , Metabolic Networks and Pathways , Photosynthesis
17.
Camb Q Healthc Ethics ; 23(3): 308-18, 2014 Jul.
Article En | MEDLINE | ID: mdl-24912565

We report on two areas in which UK law and ethics seem out of step with each other. 2013 saw the passing of the Human Transplantation (Wales) Bill, which will introduce an opt-out system of organ donation in Wales from 2015. In the first section, we discuss the convoluted evolution of the Bill and some potential problems that we consider may prevent it from achieving its intended goal of increasing the number of organs transplanted. The prospect of being able to enhance human cognition through cognitive-enhancing drugs ("smart drugs") also presents a nexus of questions associated with future ambitions, hopes, and concerns as a society. How these drugs might affect the future of work and employment is beginning to generate wide public engagement in the UK and forms the focus of the second section.


Cognitive Behavioral Therapy/ethics , Nootropic Agents , Presumed Consent/ethics , Tissue Donors/ethics , Tissue and Organ Procurement/ethics , Cognitive Behavioral Therapy/legislation & jurisprudence , Humans , Nootropic Agents/therapeutic use , Presumed Consent/legislation & jurisprudence , State Medicine , Tissue Donors/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence , United Kingdom , Wales
19.
PLoS One ; 7(2): e30729, 2012.
Article En | MEDLINE | ID: mdl-22328921

Intraflagellar transport (IFT) proteins are well established as conserved mediators of flagellum/cilium assembly and disassembly. However, data has begun to accumulate in support of IFT protein involvement in other processes elsewhere in the cell. Here, we used synchronous cultures of Chlamydomonas to investigate the temporal patterns of accumulation and localization of IFT proteins during the cell cycle. Their mRNAs showed periodic expression that peaked during S and M phase (S/M). Unlike most proteins that are synthesized continuously during G1 phase, IFT27 and IFT46 levels were found to increase only during S/M phase. During cell division, IFT27, IFT46, IFT72, and IFT139 re-localized from the flagella and basal bodies to the cleavage furrow. IFT27 was further shown to be associated with membrane vesicles in this region. This localization pattern suggests a role for IFT in cell division.


Carrier Proteins/metabolism , Chlamydomonas/metabolism , Protozoan Proteins/metabolism , Carrier Proteins/genetics , Cell Cycle/genetics , Cell Cycle/physiology , Cell Division/genetics , Cell Division/physiology , Chlamydomonas/genetics , Flagella/metabolism , Protozoan Proteins/genetics
...